Based on the Evolus Inc stock forecast from 3 analysts, the average analyst target price for Evolus Inc is USD 23.60 over the next 12 months. Evolus Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Evolus Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Evolus Inc’s stock price was USD 11.73. Evolus Inc’s stock price has changed by -2.57% over the past week, -3.14% over the past month and +18.48% over the last year.
No recent analyst target price found for Evolus Inc
No recent average analyst rating found for Evolus Inc
Company Overview Evolus Inc
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Read Less
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement...Read More
Frequently Asked Questions About Evolus Inc (EOLS) Stock
Based on ratings from 3 analysts Evolus Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and hold ratings.
Unfortunately we do not have enough data on EOLS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for EOLS is USD 23.60 over the next 12 months. The maximum analyst target price is USD 27 while the minimum anlayst target price is USD 20.
Unfortunately we do not have enough data on EOLS's stock to indicate if its overvalued.
The last closing price of EOLS's stock was USD 11.73.
The most recent market capitalization for EOLS is USD 0.87B.
Based on targets from 3 analysts, the average taret price for EOLS is projected at USD 23.60 over the next 12 months.
This means that EOLS's stock price may go up by +101.19% over the next 12 months.
We can't find any ETFs which contains Evolus Inc's stock.
As per our most recent records Evolus Inc has 322 Employees.
Evolus Inc's registered address is 520 Newport Center Drive, Newport Beach, CA, United States, 92660.
You can get more information about it from Evolus Inc's website at https://www.evolus.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Evolus Inc (EOLS) Stock
Based on ratings from 3 analysts Evolus Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and hold ratings.
Unfortunately we do not have enough data on EOLS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for EOLS is USD 23.60 over the next 12 months. The maximum analyst target price is USD 27 while the minimum anlayst target price is USD 20.
Unfortunately we do not have enough data on EOLS's stock to indicate if its overvalued.
The last closing price of EOLS's stock was USD 11.73.
The most recent market capitalization for EOLS is USD 0.87B.
Based on targets from 3 analysts, the average taret price for EOLS is projected at USD 23.60 over the next 12 months.
This means that EOLS's stock price may go up by +101.19% over the next 12 months.
We can't find any ETFs which contains Evolus Inc's stock.
As per our most recent records Evolus Inc has 322 Employees.
Evolus Inc's registered address is 520 Newport Center Drive, Newport Beach, CA, United States, 92660.
You can get more information about it from Evolus Inc's website at https://www.evolus.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EOLS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
